The Cardiovascular Health (CVH) Division is a dynamic group
that brings together experts from various fields to advance our understanding
of cardiovascular health. With a focus on laboratory diagnostics for risk
prediction-management, and treatment of cardiovascular diseases, including
coronary heart disease, stroke, heart failure, arrhythmias, and vascular
disease, our division aims to promote proactive approaches to cardiovascular
health.
Within the Cardiovascular Health Division, our members
explore the role of biomarkers in diagnosis, risk stratification, and prognosis
of cardiovascular diseases. By fostering research, innovation, and knowledge
exchange, we aim to enhance the clinical utility and analytical performance of
assays for biomarkers of cardiovascular health. Additionally, our division
provides a platform for discussions on emerging technologies, standardization,
and other critical topics in the field. Through annual educational meetings, we
share insights, advancements, and best practices related to cardiovascular
diseases.
Recognizing the significance of risk factors such as high
blood pressure, cholesterol, tobacco use, and diabetes in cardiovascular
disease development, we are committed to promoting monitoring strategies. Our
collaborative efforts, driven by a shared vision for cardiovascular health, aim
to improve outcomes, drive advancements, and contribute to the well-being and
cardiovascular wellness of individuals.
Find out more about the Division, upcoming events, and join
in the conversation with the Division at their Artery forum!
View the bylaws for this Division.
Home for former members of the Biomarkers of Acute
Cardiovascular Disease Division, Lipoproteins and Vascular Diseases Division,
Nutrition Division, and Clinical Translational Sciences Division.\
Sponsor of ADLM 2025
